KUCHING: Hong Leong Assurance (HLA) has stepped up to offer Hospitalisation Reimbursement Benefit to all of its policyholders with individual medical plans if they were to get admitted to private hospitals for Category 3, 4, or 5 Covid-19 treatment.
The categories as defined by the National Security Council are as follows:
- Category 3: Symptomatic, pneumonia
- Category 4: Symptomatic, pneumonia, requiring supplemental oxygen
- Category 5: Critically-ill with multi-organ involvement
With more private hospitals in the country providing Covid-19 care, HLA recognises the need to empower its customers with sufficient medical coverage so they can seek treatment at private hospitals.
This measure is HLA’s way of assisting its customers in managing their medical costs and enabling them to receive the best treatment, particularly during this trying time.
The coverage is given at no extra cost as it is part of HLA’s Complimentary Special Benefit Programme for Covid-19.
Policyholders are entitled to claim hospitalisation reimbursement up to their annual limit and lifetime limit, subject to the existing terms and condition of their medical plan.
The programme also offers policyholders coverage for post-vaccination complication with daily hospitalisation benefit of RM200 per day up to seven days for any problem that may arise after they received their vaccine.
As Malaysia’s leading local life insurer, HLA is constantly strategising efforts to ensure that the health and wellbeing of its customers are adequately protected during this period of uncertainty.
For more information, call any of HLA’s servicing agents, contact HLA at 03-7650 1288, visit any of the HLA branches nationwide, or log on to www.hla.com.my.
